Patents by Inventor Bonnie Jean Hanson

Bonnie Jean Hanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180202996
    Abstract: Provided are compositions and methods useful in evaluation of cell health and metabolism, cell viability, proliferation, and the effects of compounds on these qualities. The assays provided are rapid, robust, nontoxic and suitable for use with high throughput devices.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 19, 2018
    Inventor: Bonnie Jean HANSON
  • Publication number: 20160054303
    Abstract: Provided are compositions and methods useful in evaluation of cell health and metabolism, cell viability, proliferation, and the effects of compounds on these qualities. The assays provided are rapid, robust, nontoxic and suitable for use with high throughput devices.
    Type: Application
    Filed: November 3, 2015
    Publication date: February 25, 2016
    Inventor: Bonnie Jean HANSON
  • Publication number: 20130210063
    Abstract: Provided are compositions and methods useful in evaluation of cell health and metabolism, cell viability, proliferation, and the effects of compounds on these qualities. The assays provided are rapid, robust, nontoxic and suitable for use with high throughput devices.
    Type: Application
    Filed: October 13, 2011
    Publication date: August 15, 2013
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventor: Bonnie Jean Hanson
  • Publication number: 20090317858
    Abstract: The present invention provides cells and methods related to signaling receptors. The cells of the invention express the signaling receptors (e.g., in a constitutively active state). The cells are useful for analyzing the signaling receptors and their related pathways. The invention further provides methods for studying interactions of the signaling receptors and for small molecule screening, including high throughput methods. The invention further relates to expressing a signaling receptor (e.g., a GPCR) in a constitutively active state, even in the absence of the receptor's ligand. This allows for screening for inhibitors of the activated receptor's pathway without even knowing the ligand that activates the receptor, e.g., an orphan receptor. The invention further provides cell lines for expressing a signaling receptor in a constitutively active state. These cell lines are useful for high throughput screening assays of the invention.
    Type: Application
    Filed: June 17, 2009
    Publication date: December 24, 2009
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventor: Bonnie Jean Hanson